OneCarbon

Company

OneCarbon develops one asset, in human trials (1C-01 in probiotic intervention). Mostly microbiome.

1
Asset
Furthest stage
Human trials
1
Trial
2
Signals

Pipeline

1
  • 1C-01

    Probiotic supplementation intended to modulate gut microbiota.

    Human trials, Microbiome, probiotic intervention

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals2

Intelligence